Marker Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.46

+0.00 (+0.00%)

As of May 16, 2:24 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,014.4% upside

Low Target $12.16

Average Target $16.27

High Target $21.27

Current Price $1.46

Current
$1.46

Target
$16.27

$12.16 $16.27 avg $21.27

Scenario Analysis

Bear Case

$12.16

732.9%

Low target

Base Case

$16.27

+1,014.4%

Avg target

Bull Case

$21.27

+1,356.8%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$4.07

-64.1% from high

52-Week Low

$0.81

+80.3% from low

Target vs 52W High

$16.27

+299.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%